Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Mindray Medical Beats Street

publication date: Aug 8, 2007
Guides Higher for Full-Year 2007 Mindray Medical (MR), based in Shenzhen but listed on the NYSE, reported second-quarter earnings per share that were 20% above analysts estimates. Its net for the period represented a 69% increase over the year-earlier quarter, with sales to international markets leading the surge. In response to the better than expected report, management raised its forecast slightly for full-year net income to 615 million RMB ($85 million), an increase of approximately 20 million RMB (the numbers are non-GAAP net). More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here